Skip To Main Content
Guillaume Cayla on Muck Rack

Guillaume Cayla

As seen in: American Journal of Cardiovascular Drugs, MDPI, JAMA: Journal of the American Medical Association, The New England Journal of Medicine, European Heart Journal - Cardiovascular Imaging, JACC (Journal of the American College of Cardiology), Canadian Journal of Cardiology, International Journal of Cardiology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Guillaume

Contact Guillaume, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction : The AMUNDSEN Randomized Clinical Trial

|
By Gilles Montalescot, Emile Ferrari, Géraud Souteyrand, Claire Bouleti, Grégoire Rangé, Andrea Picchi, Jean-Guillaume Dillinger, Giovanni Esposito, Giuseppe Patti, Flavien Vincent, Stephane Ederhy, Pierre Coste, Sinda Hannachi, Michel Zeitouni, Paul Guedeney, Niki Procopi, Pierre Sabouret, Abdourahmane DIALLO, Karine Brochard, Mathieu Kerneis, Johanne Silvain, J. Wouter Jukema, François Mach, Holger Thiele, Leonardo Bolognese, Eric Vicaut, Denis Angoulvant, Anne Bellemain-Appaix, Farzin Beygui, Guillaume Cayla, Meyer Elbaz, Julien Plessis, Francois Schiele, Patrick Ohlmann, Fabrice Prunier, Batric Popovic, Sabrina Uhry, Marco Valgimigli, Ingo Eitel, Natalia Martinez, Xavier Marimon, Victor Diaz Verified, Alberto Alperi, Gianluca Campo, Alberto Menozzi, Marek Gierlotka, Laure Batias-Moreau, Marco Chioccioli, Nassim Braik, Nassim Redjimi, Benjamin Duband, Etienne Fourrier, Amel Chamam, Nicolas Vignolles, Angel Cequier-Fillat, Stanislaw Bartus, AMUNDSEN Investigators, Pierre Poustis, Jean-Noel Labeque, Laurent Payot, Thibaut Petroni, Guillaume Godeau, Laszlo Levai, Jacques Chan Peng, Rüdiger Christian Braun-Dullaeus
| JAMA: Journal of the American Medical Association Verified
LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: The AMUNDSEN Randomized Clinical Trial Supplement 1. Methods 1. Complete List of AMUNDSEN Sites and Investigators Methods 2. Trial Organization and Oversight Methods 3. Additional Statistical Methods eTable 1. Inclusion Criteria eTable 2. Exclusion Criteria eTable 3. Study End Points and Hierarchical Testing Order eTable 4. Study End Points definitions eTable 6.
Open in Who Shared Issue with article?

Impact of P2Y12 inhibitors pretreatment on stent thrombosis in patients undergoing percutaneous coronary intervention: insight France PCI registry

|
By Grégoire Rangé, Guillaume Cayla, Denis Angoulvant, Institut Mutualiste Montsouris, Aurélie Veugeois, Jacques Monségu, Antoine Gommeaux, Jean-François Morelle, Sylvain Chanseaume, Gilles Baron-Rochette, Julien Jeanneteau, Nicolas Durel, Antoine Py, Géraldine Gibault Genty
| Canadian Journal of Cardiology Verified
Get full text access Log in, subscribe or purchase for full access. References 1. Bellemain-Appaix, A. ∙ O’Connor, S.A. ∙ Silvain, J. ... Association of Clopidogrel Pretreatment With Mortality, Cardiovascular Events, and Major Bleeding Among Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis JAMA. 2012; 308:2507-2516 2. Collet, J-P ∙ Thiele, H. ∙ Barbato, E. ...
Open in Who Shared Issue with article?

Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation | NEJM

|
By Gilles Lemesle, Romain Didier, Martine Gilard, Guillaume Cayla
| The New England Journal of Medicine Verified
The appropriate antithrombotic regimen for patients with chronic coronary syndrome who are at high atherothrombotic risk and receiving long-term oral anticoagulation remains unknown. We conducted a multicenter, double-blind, randomized, placebo-controlled trial in France involving patients with chronic coronary syndrome who had undergone a previous stent implantation (>6 months before enrollment) and were at high atherothrombotic risk and currently receiving long-term oral anticoagulation.
Open in Who Shared View Duplicates (2) Issue with article?
See all 14 articles